← back to search

Haibin Dai

Hebei Medical University · CN
Area of research
Psychiatry and Mental health · Neurology
Research interest
Research interests include Epilepsy research and treatment, Neuroinflammation and Neurodegeneration Mechanisms, Acute Ischemic Stroke Management, and Antibiotic Resistance in Bacteria.
h-index
33
citations
3,179
works
186
NIH funding
primary concept
email

Recent publications

druglikeFilter 1.0: An AI powered filter for collectively measuring the drug-likeness of compounds
Journal of Pharmaceutical Analysis 2025cited by 7position: middledoi
Dynamic clinical trial success rates for drugs in the 21st century
Nature Communications 2025cited by 5position: middledoi
SingPro: a knowledge base providing single-cell proteomic data
Nucleic Acids Research 2023cited by 28position: middledoi
Multidisciplinary Guidelines for the Rational Use of Topical Non-Steroidal Anti-Inflammatory Drugs for Musculoskeletal Pain (2022)
Journal of Clinical Medicine 2023cited by 24position: middledoi
DrugMAP: molecular atlas and pharma-information of all drugs
Nucleic Acids Research 2022cited by 86position: middledoi
Expert consensus statement on therapeutic drug monitoring and individualization of linezolid
Frontiers in Public Health 2022cited by 69position: lastdoi
ConSIG: consistent discovery of molecular signature from OMIC data
Briefings in Bioinformatics 2022cited by 60position: middledoi
Population pharmacokinetics of oxcarbazepine 10-monohydroxy derivative in Chinese adult epileptic patients
European Journal of Hospital Pharmacy 2022cited by 6position: middledoi
Central nervous system relapse of acute promyelocytic leukemia treated by oral Venetoclax with Azacitidine achieved complete remission
Annals of Hematology 2022cited by 4position: middledoi
<p>Long Noncoding RNA SNHG12 Indicates the Prognosis and Accelerates Tumorigenesis of Diffuse Large B-Cell Lymphoma Through Sponging microR-195</p>
OncoTargets and Therapy 2020cited by 21position: lastdoi
Cerebroprotection by salvianolic acid B after experimental subarachnoid hemorrhage occurs via Nrf2- and SIRT1-dependent pathways
Free Radical Biology and Medicine 2018cited by 116position: middledoi
The Role of VE-cadherin in Blood-brain Barrier Integrity Under Central Nervous System Pathological Conditions
Current Neuropharmacology 2018cited by 116position: lastdoi
[Expression and Clinical Significance of Leukemia Stem Cell Antigen in Acute Myeloid Leukemia].
PubMed 2018cited by 0position: lastdoi
CD33, CD96 and Death Associated Protein Kinase (DAPK) Expression Are Associated with the Survival Rate and/or Response to the Chemotherapy in the Patients with Acute Myeloid Leukemia (AML)
Medical Science Monitor 2017cited by 22position: lastdoi
Chemotherapy induces enhanced procoagulant activity through phosphatidylserine exposure in acute lymphoblastic leukemia
Thrombosis Research 2013cited by 9position: middledoi
Heparin-Induced Thrombocytopenia in Chinese Patients: 240 Patients Study in One Center
Clinical Laboratory 2013cited by 2position: lastdoi
Characteristics of immunophenotype in acute lymphoblastic leukemia and its clinical significance
Harbin Yike Daxue xuebao 2012cited by 0position: first
Characteristics of abnormal immunophenotype and clinical significance in acute myelocytic leukemia
Harbin Yike Daxue xuebao 2012cited by 0position: first

Grants

No grants ingested yet.

Frequent collaborators

Feng Zhu · Hebei Medical University3 papers (2022–2025)Yinglan Jin · Harbin Medical University3 papers (2013–2018)Dandan Yao · Nanjing University of Chinese Medicine3 papers (2017–2022)Yintao Zhang · Zhejiang University3 papers (2023–2025)Jinghua Wang · Shandong University of Technology2 papers (2013–2013)Zhaorong Li · Zhejiang University2 papers (2022–2022)Xiushuai Dong · Harbin Medical University2 papers (2013–2013)Biqing Han · Harbin Medical University2 papers (2018–2020)Yunqing Qiu · Zhejiang University2 papers (2022–2025)Lianyi Han · Fudan University2 papers (2023–2025)Mingkun Lu · Zhejiang University2 papers (2022–2022)Fengcheng Li · Shenyang Agricultural University2 papers (2022–2022)Minjie Mou · Zhejiang University2 papers (2022–2025)Jiayi Yin · Guangdong University of Technology2 papers (2022–2022)Yu Chen · National University of Singapore2 papers (2022–2022)Xichen Lian · Fudan University2 papers (2023–2025)Zhenyu Zeng · Zhejiang University2 papers (2022–2022)Yanzhong Wang · King's College London1 papers (2025–2025)Yang Liao · Xihua University1 papers (2025–2025)Yanming Xue · Harbin Medical University1 papers (2013–2013)